Xiamen Comfort Science & Technology Group Co., Ltd. researches, develops, manufactures, and sells health massage appliances in China and internationally. Its products include massage chairs and appliances, fresh air systems, and air purifiers. The company offers these products under brands such as OGAWA, FUJI, IHOCO, medisana, BRI, cozzia, Enjoy Time, joypal, EASEWELL, and MICODE. Founded in 1996, it is headquartered in Xiamen, China.
OGAWA Shares Cool Down After Four Consecutive Limit-Ups; Health Service Robot Business Has Yet to Generate Sales Revenue
After OGAWA's share price hit the daily limit-up for four consecutive trading days, with a cumulative gain of about 46.65%, the company issued an announcement on abnormal stock trading fluctuations, noting that its health service robot-related business is still in an early exploration stage, does not currently involve the humanoid robot field, and as of the announcement disclosure date had not generated sales revenue, so it will not have a material impact on the company's current or near-term operating results. From September 21 to 24, OGAWA's share price hit the daily limit-up for four straight sessions. On September 21 and 22, and again on September 23 and 24, the cumulative deviation in closing price gains over two consecutive trading days exceeded 20%, triggering abnormal fluctuation disclosures, and the company released abnormal fluctuation announcements on the evenings of September 22 and September 27 respectively. After verification and inquiry with its controlling shareholders, the company disclosed that controlling shareholders Zou Jianhan and Li Wuling, along with shareholder Wei Gang, each signed share transfer agreements with Shanghai Yixin Private Fund Management Co., Ltd., planning to transfer a combined 62.3739 million shares, representing approximately 10.000% of the company's total unrestricted tradable shares. The company emphasized that in January 2026 it established a wholly owned subsidiary, Xiamen OGAWA Robot Technology Co., Ltd., to explore scenario-based applications in the vertical health service robot field, and through a fund it invested in embodied intelligence target company Xinghai Tu Beijing Artificial Intelligence Technology Co., Ltd., with a stake of less than 1%. The semi-annual report shows that in the first half of 2026, OGAWA achieved operating revenue of 2.703 billion yuan, up 16.14% year on year, while net profit attributable to shareholders of the listed company was negative 73.924 million yuan, down 373.47% year on year, and non-GAAP net profit was negative 91.5419 million yuan, down 653.35% year on year, mainly affected by foreign exchange losses of 71.7936 million yuan and losses from some non-core businesses. The company also cautioned that as of the close on September 24, 2026, its latest rolling price-to-earnings ratio was negative, while the latest rolling price-to-earnings ratio for the electrical machinery and equipment manufacturing industry was 20.67 times, a significant difference between the two.
002614.CS · Technology · Neutral OGAWA's health service robot business is still in early exploration, has no sales revenue, and does not involve humanoid robots, so the robot theme driving its limit-ups lacks near-term substance.
上海峄昕私募基金管理有限公司 · Capital · Neutral Shanghai Yixin signed agreements to acquire about 10% of OGAWA's unrestricted tradable shares from controlling shareholders, a share-transfer event with no stated operational impact.
星海图（北京）人工智能科技股份有限公司 · Capital · Neutral OGAWA's fund holds less than 1% of Xinghai Tu, a minor investment mentioned only as context for its embodied-intelligence exploration.
OGAWA's 2026 interim report shows net loss of 73.92 million yuan, swinging from profit to loss
OGAWA released its 2026 interim report. Total operating revenue was 2.703 billion yuan, and net profit attributable to the parent company was a loss of 73.924 million yuan, swinging from profit to loss. This was a decrease of 101 million yuan compared with the same period last year, a year-on-year decline of 373.47%. Net cash inflow from operating activities was 241 million yuan, the asset-liability ratio was 40.10%, the gross margin was 31.31%, and diluted earnings per share was negative 0.12 yuan. The number of shareholders was 35,500, and the top ten shareholders held 42.38% of the total share capital.
2026 World Robot Conference to be held; multiple listed companies disclose robotics plans
The 2026 World Robot Conference will be held from August 19 to 23, 2026, alongside the World Robot Expo and the World Robot Contest. ThunderSoft said its full range of mobile robot products includes core offerings such as latent mobile robots, forklift robots, and composite and embodied robots. In January 2026, its subsidiary Hangzhou Xiaowu Intelligent Co., Ltd. signed a strategic cooperation agreement with the Beijing Humanoid Robot Innovation Center, and the two sides will carry out in-depth cooperation on the large-scale application of humanoid robots in vertical scenarios such as automobile manufacturing, warehousing and logistics, and commercial services. OGAWA said the company is accelerating its embodied intelligence business layout and exploring scenario-based application implementation of health service robots in vertical fields. Ningbo Huaxiang said its subsidiary Huaxiang Qiyuan will have a booth at the World Robot Conference to showcase its latest bipedal and quadruped robot bodies as well as lightweight joint components and skeletal parts. Bojay Electronics said that in response to the needs of humanoid robots for electronic eye observation, electronic skin tactile sensing, and microphone sound reception, it has developed testing technologies adapted to humanoid robot cameras, force sensors, and microphones.
Robotics & Physical AI › Industrial Automation & Cobots ▲Demand
Robotics & Physical AI › Consumer & Home Service Robots Demand
300496.CS · Demand · Positive Signed strategic cooperation with Beijing Humanoid Robot Innovation Center for large-scale application in vertical scenarios.
002048.CS · Demand · Positive Subsidiary will showcase bipedal and quadruped robot bodies and components at the World Robot Conference, indicating product demand.
002975.CS · Technology · Positive Developed testing technologies for humanoid robot cameras, force sensors, and microphones, aligning with industry needs.
002614.CS · Technology · Neutral Company is accelerating embodied intelligence business layout and exploring health service robot applications, but no concrete development.
OGAWA's German Subsidiary Pays 2.29 Million Euros in Back Taxes and Late Fees
OGAWA announced that its wholly-owned German subsidiary, MEDISANA GmbH, has completed the payment of back taxes and late fees totaling 2.29 million euros, equivalent to approximately 17.82 million yuan. The German tax authorities had initially demanded 2.39 million euros, but after negotiations the amount was reduced to 2.29 million euros, covering the period from 2019 to 2021. In the first quarter of 2026, the company achieved revenue of 1.276 billion yuan, with a net loss attributable to the parent company of 66.14 million yuan.
OGAWA Sees First-Half 2026 Net Loss Attributable to Parent at 60 Million to 90 Million Yuan
OGAWA disclosed an earnings forecast, expecting a net loss attributable to the parent of 60 million to 90 million yuan for the first half of 2026, compared with a profit of 27.03 million yuan in the same period last year. The net loss after deducting non-recurring items is expected to be 78 million to 117 million yuan, versus a profit of 16.54 million yuan a year earlier. The company said the change in performance was mainly due to the appreciation of the renminbi exchange rate, market competition, and changes in product sales mix leading to a decline in gross margin. Meanwhile, the depreciation of foreign currencies against the renminbi resulted in an exchange loss of about 72 million yuan, compared with an exchange gain of 62.49 million yuan in the same period last year. In addition, it plans to make an asset impairment provision of about 23 million yuan.
002614.CS · Capital · Negative Company forecasts net loss for first-half 2026, citing exchange losses, competition, and product mix changes.
USDCNY.FOREX · Monetary · Negative Article states renminbi appreciation and foreign currency depreciation against renminbi, which strengthens CNY relative to USD.
China